newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces Second Quarter 2023 Financial Results

TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ:TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023. "The